We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VINO
4726
DELISTED
Gaucho Group Holdings, Inc. Common Stock
VINO
$8K ﹤0.01%
11
+9
+450% +$14.7K
CSML
4727
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
$8K ﹤0.01%
259
+232
+859% +$7.46K
NEPT
4728
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$8K ﹤0.01%
+152
New +$30.9K
LMDX
4729
DELISTED
LumiraDx Limited Common Shares
LMDX
$8K ﹤0.01%
2,908
-1,188
-29% -$4.76K
CD
4730
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
$8K ﹤0.01%
1,081
-7,749
-88% -$50K
CZOO
4731
DELISTED
Cazoo Group Ltd
CZOO
$8K ﹤0.01%
+6
New +$19.8K
SURF
4732
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$8K ﹤0.01%
4,994
-19,797
-80% -$41.1K
QUOT
4733
DELISTED
Quotient Technology Inc
QUOT
$8K ﹤0.01%
2,775
-27,059
-91% -$128K
SPPI
4734
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$8K ﹤0.01%
10,169
-8,780
-46% -$7.74K
SDAC
4735
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$8K ﹤0.01%
+832
New +$8.16K
IMBI
4736
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$8K ﹤0.01%
6,483
+6,104
+1,611% +$17.4K
KBAL
4737
DELISTED
Kimball International
KBAL
$8K ﹤0.01%
1,106
-1,650
-60% -$13.5K
CDAK
4738
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$8K ﹤0.01%
2,793
+1,168
+72% +$4.1K
MLAI
4739
DELISTED
McLaren Technology Acquisition Corp. Class A Common Stock
MLAI
$8K ﹤0.01%
+805
New +$8.04K
BIOT
4740
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$8K ﹤0.01%
850
-146
-15% -$1.43K
HCAR
4741
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$8K ﹤0.01%
782
-1,254
-62% -$12.3K
TSIBU
4742
DELISTED
Tishman Speyer Innovation Corp. II Unit
TSIBU
$8K ﹤0.01%
855
+854
+85,400% +$8.4K
LOGC
4743
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$8K ﹤0.01%
22,096
+9,535
+76% +$4.82K
CNTQU
4744
DELISTED
Chardan NexTech Acquisition 2 Corp. Unit
CNTQU
$8K ﹤0.01%
761
-506
-40% -$5.17K
AVAN
4745
DELISTED
Avanti Acquisition Corp.
AVAN
$8K ﹤0.01%
831
+124
+18% +$1.23K
NBEV
4746
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$8K ﹤0.01%
35,008
+12,696
+57% +$4.79K
FST
4747
DELISTED
FAST Acquisition Corp.
FST
$8K ﹤0.01%
797
-64
-7% -$646
LBPS
4748
DELISTED
4D Pharma PLC
LBPS
$8K ﹤0.01%
4,643
-3,863
-45% -$13.1K
PBLA
4749
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$8K ﹤0.01%
+1
New +$37K
PTE
4750
DELISTED
PolarityTE, Inc. Common Stock
PTE
$8K ﹤0.01%
5,585
+3,319
+146% +$12K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.